Published in Proc Natl Acad Sci U S A on May 26, 1998
The use of mRNA display to select high-affinity protein-binding peptides. Proc Natl Acad Sci U S A (2001) 2.63
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J Mol Biol (2008) 1.64
scFv antibody: principles and clinical application. Clin Dev Immunol (2012) 1.64
Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A (2001) 1.56
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J Mol Biol (2007) 1.48
Virus-based chemical and biological sensing. Angew Chem Int Ed Engl (2009) 1.33
Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display. Infect Immun (2001) 1.24
A method for the generation of combinatorial antibody libraries using pIX phage display. Proc Natl Acad Sci U S A (2002) 1.18
Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. PLoS One (2012) 1.13
Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J (2003) 1.12
A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region. J Mol Biol (2010) 1.10
Selecting open reading frames from DNA. Genome Res (2003) 1.10
By-passing selection: direct screening for antibody-antigen interactions using protein arrays. Nucleic Acids Res (2000) 1.09
A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol (2009) 1.08
Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol Immunol (2007) 1.07
Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies. Mol Cancer Ther (2008) 1.04
Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display. Protein Eng Des Sel (2010) 1.02
Eliminating helper phage from phage display. Nucleic Acids Res (2006) 0.99
Antibodies to human fetal erythroid cells from a nonimmune phage antibody library. Proc Natl Acad Sci U S A (2001) 0.98
Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization. Nat Biotechnol (2010) 0.97
Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing. J Exp Med (1999) 0.96
Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites. Antimicrob Agents Chemother (2012) 0.95
A novel assay for monitoring internalization of nanocarrier coupled antibodies. BMC Immunol (2006) 0.95
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors. Infect Immun (1999) 0.94
Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. BMC Biotechnol (2007) 0.94
Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLoS One (2011) 0.93
Mining human antibody repertoires. MAbs (2010) 0.92
Recombinatorial cloning using heterologous lox sites. Genome Res (2004) 0.92
Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion. J Mol Med (Berl) (2009) 0.92
Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells. Mol Cancer Ther (2010) 0.91
Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens. J Mol Biol (2010) 0.89
Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One (2012) 0.88
Isolation of human monoclonal antibodies that neutralize human rotavirus. J Virol (2004) 0.87
A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes. BMC Biotechnol (2004) 0.85
Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. Biotechnol Prog (2013) 0.85
Antibody library screens using detergent-solubilized mammalian cell lysates as antigen sources. Protein Eng Des Sel (2010) 0.84
Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments. Mol Cancer Ther (2014) 0.84
Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture. Nat Protoc (2009) 0.83
Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources. Protein Eng Des Sel (2012) 0.82
Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens. Infect Immun (2002) 0.82
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism. MAbs (2009) 0.82
Drop-out phagemid vector for switching from phage displayed affinity reagents to expression formats. Anal Biochem (2011) 0.82
Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection. Acta Naturae (2009) 0.81
Isolation and characterization of antibody fragments selective for toxic oligomeric tau. Neurobiol Aging (2014) 0.80
Novel atomic force microscopy based biopanning for isolation of morphology specific reagents against TDP-43 variants in amyotrophic lateral sclerosis. J Vis Exp (2015) 0.80
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation. Leukemia (2015) 0.80
Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies. MAbs (2013) 0.79
Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malar J (2014) 0.79
Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. PLoS One (2015) 0.79
Protein expression profiling arrays: tools for the multiplexed high-throughput analysis of proteins. Proteome Sci (2003) 0.78
Human scFv antibody fragments specific for hepatocellular carcinoma selected from a phage display library. World J Gastroenterol (2005) 0.78
High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display. PLoS One (2014) 0.78
A library of bacteriophage-displayed antibody fragments directed against proteins of the inner ear. Proc Natl Acad Sci U S A (2000) 0.78
Improved Protein-A separation of V(H)3 Fab from Fc after papain digestion of antibodies. J Biomol Tech (2011) 0.78
Synthetic approach to the generation of antibody diversity. BMB Rep (2015) 0.78
Combining Phage and Yeast Cell Surface Antibody Display to Identify Novel Cell Type-Selective Internalizing Human Monoclonal Antibodies. Methods Mol Biol (2015) 0.77
Selection and characterization of cell binding and internalizing phage antibodies. Arch Biochem Biophys (2012) 0.77
Targeting membrane proteins for antibody discovery using phage display. Sci Rep (2016) 0.77
Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization. Mol Med (1999) 0.77
Discovery of internalizing antibodies to tumor antigens from phage libraries. Methods Enzymol (2012) 0.77
Identifying blood-brain-barrier selective single-chain antibody fragments. Biotechnol J (2014) 0.77
A fully human scFv phage display library for rapid antibody fragment reformatting. Protein Eng Des Sel (2015) 0.77
Large scale production of phage antibody libraries using a bioreactor. MAbs (2015) 0.77
An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification. MAbs (2012) 0.76
pMINERVA: A donor-acceptor system for the in vivo recombineering of scFv into IgG molecules. J Immunol Methods (2016) 0.76
Continuous affinity-based selection: rapid screening and simultaneous amplification of bacterial surface-display libraries. Biochem J (2001) 0.76
The clinical potential of circulating tumor cells; the need to incorporate a modern "immunological cocktail" in the assay. Cancers (Basel) (2013) 0.76
TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS. Am J Transl Res (2010) 0.76
Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease. Protein Eng Des Sel (2014) 0.76
Platform for high-throughput antibody selection using synthetically-designed antibody libraries. N Biotechnol (2015) 0.76
Expression cloning of camelid nanobodies specific for Xenopus embryonic antigens. PLoS One (2014) 0.75
State of the art in tumor antigen and biomarker discovery. Cancers (Basel) (2011) 0.75
Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library. J Immunol Methods (2008) 0.75
TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis. BMC Neurosci (2017) 0.75
Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo. J Antivir Antiretrovir (2009) 0.75
Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay. PLoS One (2017) 0.75
The library of human miniantibodies in the phage display format: designing and testing. Dokl Biochem Biophys (2006) 0.75
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
The new genomics: global views of biology. Science (1996) 10.77
Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 8.67
By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 6.14
Making antibodies by phage display technology. Annu Rev Immunol (1994) 5.04
Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem (1991) 4.82
Making antibody fragments using phage display libraries. Nature (1991) 4.61
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol (1996) 4.45
Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene (1988) 4.14
Direct clone characterization from plaques and colonies by the polymerase chain reaction. Nucleic Acids Res (1989) 3.98
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res (1991) 3.89
Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J (1994) 3.68
Kinetic maturation of an immune response. Nature (1991) 3.26
The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol (1992) 3.19
Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell (1992) 3.07
Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol (1992) 2.50
A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc Natl Acad Sci U S A (1994) 2.40
Length distribution of CDRH3 in antibodies. Proteins (1993) 2.12
Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc Natl Acad Sci U S A (1993) 2.10
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Chlamydia trachomatis RNA polymerase major sigma subunit. Sequence and structural comparison of conserved and unique regions with Escherichia coli sigma 70 and Bacillus subtilis sigma 43. J Biol Chem (1990) 2.04
Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J (1994) 2.02
Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. J Biol Chem (1992) 1.95
Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol (1996) 1.90
Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol (1991) 1.80
A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol (1994) 1.44
Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (N Y) (1993) 1.40
Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J Mol Biol (1995) 1.39
Sequence and evolution of the human germline V lambda repertoire. J Mol Biol (1996) 1.27
A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: roles of animal pole tissue in the development of ventral mesoderm. Proc Natl Acad Sci U S A (1994) 1.19
Regulation of the fibroblast growth factor receptor in early Xenopus embryos. Proc Natl Acad Sci U S A (1990) 1.12
Phage libraries--a new route to clinically useful antibodies. N Engl J Med (1996) 1.11
Intrabodies: turning the humoral immune system outside in for intracellular immunization. Gene Ther (1997) 0.96
Intracellular immunization with cytosolic recombinant antibodies. Biotechnology (N Y) (1994) 0.94
A carboxyl-terminal truncated version of the activin receptor mediates activin signals in early Xenopus embryos. FEBS Lett (1992) 0.91
Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol (1997) 0.91
A strong propensity toward loop formation characterizes the expressed reading frames of the D segments at the Ig H and T cell receptor loci. Eur J Immunol (1991) 0.83
Recombinant immunotoxins. Breast Cancer Res Treat (1996) 0.79
Mutation of human short tandem repeats. Hum Mol Genet (1993) 14.03
Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (1997) 8.24
Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86
Junior doctors' hours. Members of Junior Doctors Committee are in cloud cuckoo land. BMJ (1995) 7.84
Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01
The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis. Nature (2008) 5.42
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
Distinct subunits for the regulation and catalytic activity of aspartate transcarbamylase. Biochemistry (1965) 4.76
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75
Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64
A study of the quality of life and cost-utility of renal transplantation. Kidney Int (1996) 4.51
Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol (1995) 4.47
Airway management for trauma patients with potential cervical spine injuries. Anesth Analg (1991) 4.38
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Conditions Affecting Enzyme Synthesis in Cotyledons of Germinating Seeds. Plant Physiol (1960) 3.69
Microtubules from mammalian brain: some properties of their depolymerization products and a proposed mechanism of assembly and disassembly. Proc Natl Acad Sci U S A (1974) 3.59
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol (1992) 3.19
The purification of aspartate transcarbamylase of Escherichia coli and separation of its protein subunits. J Biol Chem (1967) 3.17
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res (2001) 2.90
The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol (1991) 2.69
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet (1995) 2.62
p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev (1999) 2.58
Partial purification and characterization of the maturation-promoting factor from eggs of Xenopus laevis. Dev Biol (1980) 2.53
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Changes in protein phosphorylation accompanying maturation of Xenopus laevis oocytes. Dev Biol (1977) 2.31
The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont. New Phytol (2011) 2.29
Effect of a media-led education campaign on breast and cervical cancer screening among Vietnamese-American women. Prev Med (1999) 2.28
Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science (1987) 2.27
Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol (1997) 2.25
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol (2004) 2.24
Allosteric interactions in aspartate transcarbamylase. II. Evidence for different conformational states of the protein in the presence and absence of specific ligands. Biochemistry (1968) 2.16
Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus. Infect Immun (1988) 2.13
Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther (1999) 2.11
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol (1996) 2.08
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
Hospitalization in an urban homeless population: the Honolulu Urban Homeless Project. Ann Intern Med (1992) 2.04
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol (1999) 2.03
Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol (1995) 2.03
Is hand, foot and mouth disease associated with meteorological parameters? Epidemiol Infect (2010) 1.99
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med (1998) 1.95
Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol (2006) 1.92
Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol (1996) 1.90
Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry (2000) 1.85
Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A (1999) 1.81
Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci (2001) 1.81
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80
Genetic linkage map of human chromosome 21. Genomics (1988) 1.79
ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol (1997) 1.72
Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest (1990) 1.71
Allosteric interactions in aspartate transcarbamylase. I. Binding of specific ligands to the native enzyme and its isolated subunits. Biochemistry (1968) 1.71
Purification and characterization of initiation factor IF-E2 from rabbit reticulocytes. J Biol Chem (1976) 1.66
Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis (1988) 1.65
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort. Aliment Pharmacol Ther (2010) 1.65
Isolation and partial characterization of regulatory mutants of the pyrimidine pathway in Salmonella typhimurium. J Bacteriol (1972) 1.64
On the origin and spread of beta-thalassemia: recurrent observation of four mutations in different ethnic groups. Proc Natl Acad Sci U S A (1986) 1.63
Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol (2005) 1.62
Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood (2001) 1.61
Selection of tumor-specific internalizing human antibodies from phage libraries. J Mol Biol (2000) 1.60
Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. Cancer Res (1998) 1.57
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant (2005) 1.56
Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis (2012) 1.56
Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries. Infect Immun (1997) 1.56
Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A (2001) 1.56
Tumor targeting using anti-her2 immunoliposomes. J Control Release (2001) 1.56
A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo. J Thromb Haemost (2009) 1.55
A comparison of diagnostic tests to determine Helicobacter pylori infection. J Gastroenterol Hepatol (1992) 1.54
Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci (2000) 1.54
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry (2010) 1.51
Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Obstet Gynecol (1997) 1.50
Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer (2006) 1.48
Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and the importance of urethral site sampling to detect Chlamydia trachomatis in women. Genitourin Med (1997) 1.44
Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (N Y) (1993) 1.40
Junior doctors' hours. Alternative representative body is needed. BMJ (1996) 1.38
In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library. Immunotechnology (1995) 1.38
Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci (1999) 1.38
Adaptive mutation sequences reproduced by mismatch repair deficiency. Proc Natl Acad Sci U S A (1995) 1.37
Microtubule-mediated transport of organelles and localization of beta-catenin to the future dorsal side of Xenopus eggs. Proc Natl Acad Sci U S A (1997) 1.36
Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods (2001) 1.36
Characterization of a nondeleterious L1 insertion in an intron of the human factor VIII gene and further evidence of open reading frames in functional L1 elements. Genomics (1989) 1.36
At least two mutant alleles of ornithine delta-aminotransferase cause gyrate atrophy of the choroid and retina in Finns. Proc Natl Acad Sci U S A (1989) 1.35
Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J Clin Microbiol (2001) 1.32
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30